<unk> , sold under the brand name Synjardy among others, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It contains<unk>  and metformin hydrochloride. It is taken by mouth. The most common side effects include hypoglycaemia (low blood sugar levels) when the medicine is taken with a sulphonylurea or insulin, infections of the urinary tract and genitals, and increased urination. It was approved for use in the European Union in May 2015, for use in the United States in August 2015, and for use in Australia in May 2020.
Empagliflozin/metformin
Canagliflozin/metformin
Dapagliflozin/metformin
Pioglitazone/metformin
Glibenclamide/metformin
Insulin degludec/liraglutide
Dapagliflozin/saxagliptin/metformin
Dapagliflozin/saxagliptin